Gemifloxacin API Manufacturer in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Gemifloxacin API Manufacturer and Bulk Supplier in India

Gemifloxacin API (CAS No: 175463-14-6)

 

Gemifloxacin API (CAS No. 175463-14-6) is a synthetic fluoroquinolone antibacterial active pharmaceutical ingredient associated with respiratory, antibacterial, and anti-infective pharmaceutical development.

Gemifloxacin belongs to the fluoroquinolone class of antibacterial compounds and is associated with activity against susceptible Gram-positive and Gram-negative microorganisms.

Gemifloxacin acts by inhibiting bacterial DNA gyrase and topoisomerase IV. These essential bacterial enzymes are involved in DNA replication, transcription, repair, and chromosome separation.

Inhibition of bacterial topoisomerase enzymes interferes with DNA synthesis and bacterial cell multiplication, producing bactericidal antibacterial activity against susceptible microorganisms.

Gemifloxacin is particularly associated with respiratory antibacterial pharmaceutical applications and has been developed in oral pharmaceutical products for selected bacterial respiratory tract infections.

Pharmaceutical companies sourcing Gemifloxacin API commonly evaluate assay, HPLC purity, stereochemical identity, geometric isomer profile, related substances, process-related impurities, degradation products, residual solvents, water content, crystalline characteristics, particle size distribution, and batch-to-batch consistency.

Control of Gemifloxacin-related impurities is an important quality consideration during API qualification. Pharmaceutical buyers may evaluate E-isomer or geometric isomer impurities, synthesis-related compounds, degradation products, residual solvents, and chromatographic purity according to the approved product specification.

Gemifloxacin free compound and Gemifloxacin Mesylate should be treated as separate pharmaceutical material identities. Procurement, formulation, quality, and regulatory teams should confirm the exact free compound or mesylate salt form before commercial sourcing.

Swapnroop Drugs and Pharmaceuticals supplies Gemifloxacin API for qualified pharmaceutical research, antibacterial drug development, respiratory formulation development, analytical, generic pharmaceutical development, and regulated manufacturing requirements with product-specific quality documentation, pharmaceutical-grade packaging, and reliable supply-chain coordination.

Get Bulk Quote via WhatsApp